Tumour lysis syndrome and the anaesthesiologist: Intensive care aspects of paediatric oncology
- 1 January 1990
- journal article
- case report
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 6 (3) , 156-161
- https://doi.org/10.1002/ssu.2980060306
Abstract
Children presenting with advanced leukaemia and non-Hodgkin's lymphoma may develop life-threatening complications in the early stages of management. Major metabolic disturbances with encephalopathy, septicaemic shock, pneumonitis, massive haemorrhage, or the physical effects of tumour masses may on occasion warrant intensive therapy. Close liaison between paediatric oncologists, oncological surgeons, and anesthesiologists is essential in establishing admission criteria for such cases and in defining therapeutic end points in the event of multisystem failure. This paper discusses the principles of intensive care management of patients with haematological malignancies by considering two cases who developed the tumour lysis syndrome with respiratory and renal failure. A case associated with metabolic encephalopathy is also described.Keywords
This publication has 18 references indexed in Scilit:
- Improvements in survival from childhood cancer: results of a population based survey over 30 yearsBMJ, 1988
- Who needs pulse oximetry?BMJ, 1988
- Pseudohyperkalaemia.BMJ, 1985
- Anasthesia and mediastinal masses A case report and review of the literatureAnaesthesia, 1984
- Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma.BMJ, 1979
- Cardiac arrest due to hyperkalemia following therapy for acute lymphoblastic leukemiaCancer, 1977
- Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemiaThe American Journal of Medicine, 1977
- American Burkitt's lymphoma: A clinicopathologic study of 30 casesThe American Journal of Medicine, 1975
- HYPERKALÆMIA, A SEQUEL TO CHEMOTHERAPY OF BURKITT'S LYMPHOMAThe Lancet, 1973
- Xanthine Nephropathy in a Patient with Lymphosarcoma Treated with AllopurinolNew England Journal of Medicine, 1970